Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia

Inclusion Criteria: * Diagnosed as hyperuricemia; and * Fasting blood uric acid level ≥ 7-11.0 mg/dL after 1 month of low-purine diet; and * Without history of gouty arthritis; and * Without drug treatment for hyperuricemia or stop uric acid-lowering drug treatment ≥12 weeks; and * 18.5kg/m2≤BMI≤30.0kg/ m2; and * Able to signing a informed consent. Exclusion Criteria: * Those who are using or have used one of the following drugs for the treatment of hyperuricemia 12 weeks before eligibility evaluation, such as: allopurinol, benzbromarone, probesulfan, bugelone, toppirosteine, Busotan; and * Patients are using or used other drugs that affect uric acid metabolism in the past 12 weeks, such as: thiazide diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, compound reserpine, pyrazinamide, nitrates fendipine, propranolol, and benzbromarone; and * Patients have history of gouty arthritis; and * Combined with secondary hyperurmicema, such as bone marrow and lymphoproliferative diseases, tumor radiotherapy and chemotherapy, liver cirrhosis and drug-induced hyperurmicema; and * Combined with one of the following comorbidities: hypertension, diabetes, stroke, coronary heart disease, severe liver and kidney damage (≥CKD stage 2, or high creatinine, urea, glutamate, glutamate ≥ 2 times of the limit of clinical normal values); and * Combined with severe neuropsychological diseases, such as severe anxiety, depression, and intellectual disability; and * Pregnant women; and * Unwilling to accept acupuncture treatment; and * Illiterate, or patients unable to sign informed consent; and * The completion rate of baseline screening data is ≤80%.